Your Shopping Cart Is Empty
| Report Code: A06113 | Mar 2020 | Pages: 206 | ||
| Tables: 90 | Charts: 46 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Thyroid Function Test Market
Request Now !The thyroid function test market size was valued at $1,190 million in 2018, and is projected to reach $1,807 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.
Thyroid gland is a butterfly shaped gland located at the base of the neck. Furthermore, the gland produces hormones such as triiodothyronine (T3), and thyroxine (T4). In addition, these hormones are responsible in production and regulation of the hormones such as adrenaline and dopamine. Moreover, adrenaline and dopamine play a major role in emotional responses such as fear, excitement, and pleasure. In addition, hormones from this gland also aid the regulation of metabolism. Hence, the underproduction, and overproduction of these hormones can lead serious health deteriorations. Therefore, the testing of the level of these hormones in the body is highly essential. Thyroid function test involves series of blood tests used to measure adequacy of the levels of thyroid hormones. These blood tests can define whether the thyroid hormone production is normal, overactive, or underactive. It involves the different types of test such as T3, T4, TSH, and T3RU. In addition, these tests are conducted in diagnostic laboratories which are equipped with instruments which are used by medical professionals to carry out these tests. Furthermore, these tests are also carried out in hospitals where thyroid related diseases are diagnosed by specialists.
The global thyroid function test market is expected to exhibit significant growth during the forecast period, owing to increase in prevalence of thyroid disorders. For instance, approximately, 20 million Americans are suffering from some form of thyroid disease, and up to 60% of those with thyroid disease are unaware of their condition. In addition, factors such as increase in awareness for early screening of disease, and presence of advanced diagnostic laboratories also fuel the growth of thyroid function test market. Furthermore, early detection of the disease, increase in number of geriatric population, and rise in number of awareness campaigns in developing countries further support the market growth of thyroid function test market. However, lack of insurance coverage for thyroid testing hampers the market growth. Conversely, growth potential exhibited by developing countries provide lucrative opportunities during the forecast period.
Global Thyroid Function Test Market Segmentation
The global thyroid function test market is segmented into test type, end user, and region. On the basis of test type, the market is classified into TSH tests, T3 tests, T4 tests, and others. According to end user, the market is categorized into hospitals, diagnostic laboratories, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
Segment review
Depending on test type, the market is divided into TSH tests, T3 tests, T4 tests, and others. The TSH tests is the major revenue contributor, and is expected to show significant growth during the forecast period, due to preferable usage of TSH tests for preliminary screening of the disease and rise in target population. Furthermore, according to the Office on Women's Health, 1 in 8 females experience thyroid problems at some point, which is expected to drive the demand for TSH tests, thereby augmenting the growth of the global market.
According to end user, the diagnostic laboratories segment accounted for the highest revenue in 2018, and is anticipated to dominate the market during the forecast period. This is attributed to large presence with higher preference for diagnostic laboratories for thyroid testing. Furthermore, hospitals segment is expected to grow with the highest CAGR during the forecast period owing to surge in awareness related to early diagnosis of disorders related to thyroid function. In addition, factors such as rise in number of specialized hospitals and surge in healthcare expenditure across the globe are other major factors that contribute to the growth of the market.
North America accounted the major share of the thyroid function test market. This is attributable to the factors such as easy availability of thyroid function tests, presence of skilled healthcare professionals and surge in prevalence of thyroid relate disorders drive the growth of the market. Asia-Pacific presents lucrative opportunities for the key players operating in the thyroid function test market, owing to rise in awareness about thyroid function tests and alarming increase in the prevalence of thyroid disorders. Moreover, improvement in healthcare infrastructure, rise in target population, surge in public healthcare awareness campaigns, increase in healthcare reforms, and technological advancements in the field of healthcare significantly contribute toward the market growth. In addition, factors such as surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high growth potential. Furthermore, the presence of large patient base is a key factor that fuels the demand for thyroid function tests, thereby boosting the growth of the Asia-Pacific market.
The key players profiled in this report include Abbott Laboratories, Biomerieux, Danaher Corporation, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin, F. Hoffmann-La Roche AG, KRONUS, Merck KGaA, Qualigen Inc., and ThermoFisher Scientific
Thyroid Function Test Market Report Highlights
| Aspects | Details |
|---|---|
| By Test Type |
|
| By End User |
|
| By Region |
|
| Key Market Players | Abbott Laboratories, Danaher Corporation, ThermoFisher Scientific, DiaSorin, Diagnostic Automation/Cortez Diagnostics Inc., Merck KGaA, Qualigen Inc., Biomerieux, KRONUS, F. Hoffmann-La Roche AG |
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.2.2. Market player positioning, 2018
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping thyroid function test industry/market
3.2.1. Moderate power of suppliers
3.2.2. High threat of new entrants
3.2.3. High threat of substitution
3.2.4. Moderate competitive rivalry
3.2.5. Moderate bargaining power of buyers
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in prevalence of thyroid disorders
3.3.1.2. Increase in number of geriatric population
3.3.1.3. Surge in healthcare expenditure worldwide
3.3.2. Restraint
3.3.2.1. Lack of awareness in under developed nations
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.4. Impact analysis
CHAPTER 4: THYROID FUNCTION TEST MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. TSH tests
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. T3 Tests
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. T4 tests
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: THYROID FUNCTION TEST MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostic Laboratories
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Hospitals
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
CHAPTER 6: THYROID FUNCTION TEST MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. thyroid function test market, by test type
6.2.2.1.2. U.S. thyroid function test market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada thyroid function test market, by test type
6.2.2.2.2. Canada thyroid function test market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico thyroid function test market, by test type
6.2.2.3.2. Mexico thyroid function test market, by end user
6.2.3. North America market size and forecast, by test type
6.2.4. North America thyroid function test market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany thyroid function test market, by test type
6.3.2.1.2. Germany thyroid function test market, by end user
6.3.2.2. France
6.3.2.2.1. France thyroid function test market, by test type
6.3.2.2.2. France thyroid function test market, by end user
6.3.2.3. UK
6.3.2.3.1. UK thyroid function test market, by test type
6.3.2.3.2. UK thyroid function test market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy thyroid function test market, by test type
6.3.2.4.2. Italy thyroid function test market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain thyroid function test market, by test type
6.3.2.5.2. Spain thyroid function test market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe thyroid function test market, by test type
6.3.2.6.2. Rest of Europe thyroid function test market, by end user
6.3.3. Europe market size and forecast, by test type
6.3.4. Europe thyroid function test market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan thyroid function test market, by test type
6.4.2.1.2. Japan thyroid function test market, by end user
6.4.2.2. China
6.4.2.2.1. China thyroid function test market, by test type
6.4.2.2.2. China thyroid function test market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia thyroid function test market, by test type
6.4.2.3.2. Australia thyroid function test market, by end user
6.4.2.4. India
6.4.2.4.1. India thyroid function test market, by test type
6.4.2.4.2. India thyroid function test market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea thyroid function test market, by test type
6.4.2.5.2. South Korea thyroid function test market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific thyroid function test market, by test type
6.4.2.6.2. Rest of Asia-Pacific thyroid function test market, by end user
6.4.3. Asia-Pacific market size and forecast, by test type
6.4.4. Asia-Pacific thyroid function test market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil thyroid function test market, by test type
6.5.2.1.2. Brazil thyroid function test market, by end user
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia thyroid function test market, by test type
6.5.2.3.2. Saudi Arabia thyroid function test market, by end user
6.5.2.4. South Africa
6.5.2.4.1. South Africa thyroid function test market, by test type
6.5.2.4.2. South Africa thyroid function test market, by end user
6.5.2.5. Rest of LAMEA
6.5.2.5.1. Rest of LAMEA thyroid function test market, by test type
6.5.2.5.2. Rest of LAMEA thyroid function test market, by end user
6.5.3. LAMEA market size and forecast, by test type
6.5.4. LAMEA thyroid function test market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Biomerieux
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Danaher Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Diagnostic Automation/Cortez Diagnostics Inc.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. DiaSorin
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. F. Hoffmann-La Roche AG
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. KRONUS
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. Merck KGaA
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Qualigen Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. ThermoFisher Scientific
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026 ($MILLION)
TABLE 02. TSH TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. T3 TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. T4 TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. OTHERS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. GLOBAL THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 07. DIAGNOSTIC LABORATORIES THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. HOSPITALS THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. OTHERS THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. THYROID FUNCTION TEST MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 11. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 12. U.S. THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 13. U.S. THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 14. CANADA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 15. CANADA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 16. MEXICO THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 17. MEXICO THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 18. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 19. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 20. EUROPE THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 21. GERMANY THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 22. GERMANY THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 23. FRANCE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 24. FRANCE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 25. UK THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 26. UK THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 27. ITALY THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 28. ITALY THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 29. SPAIN THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 30. SPAIN THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 31. REST OF EUROPE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 32. REST OF EUROPE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 33. EUROPE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 34. EUROPE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 35. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 36. JAPAN THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 37. JAPAN THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 38. CHINA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 39. CHINA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 40. AUSTRALIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 41. AUSTRALIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 42. INDIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 43. INDIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 44. SOUTH KOREA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 45. SOUTH KOREA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 46. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 47. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 48. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 49. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 50. LAMEA THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 51. BRAZIL THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 52. BRAZIL THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 53. SAUDI ARABIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 54. SAUDI ARABIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 55. SOUTH AFRICA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 56. SOUTH AFRICA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 57. REST OF LAMEA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 58. REST OF LAMEA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 59. LAMEA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 60. LAMEA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 61. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 62. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 63. ABBOTT LABORATORIES PLC: PRODUCT PORTFOLIO
TABLE 64. BIOMERIEUX: COMPANY SNAPSHOT
TABLE 65. BIOMERIEUX: OPERATING SEGMENTS
TABLE 66. BIOMERIEUX: PRODUCT PORTFOLIO
TABLE 67. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 68. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 69. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 70. DACDI: COMPANY SNAPSHOT
TABLE 71. DACDI: OPERATING SEGMENTS
TABLE 72. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 73. DIASORIN: COMPANY SNAPSHOT
TABLE 74. DIASORIN: OPERATING SEGMENTS
TABLE 75. DIASORIN: PRODUCT PORTFOLIO
TABLE 76. ROCHE: COMPANY SNAPSHOT
TABLE 77. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: OPERATING SEGMENTS
TABLE 78. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 79. KRONUS.: COMPANY SNAPSHOT
TABLE 80. KRONUS.: OPERATING SEGMENTS
TABLE 81. KRONUS: PRODUCT PORTFOLIO
TABLE 82. MERCK KGAA: COMPANY SNAPSHOT
TABLE 83. MERCK KGAA INC.: OPERATING SEGMENTS
TABLE 84. MERCK KGAA INC.: PRODUCT PORTFOLIO
TABLE 85. QUALIGEN INC.: COMPANY SNAPSHOT
TABLE 86. QUALIGEN INC.: PRODUCT SEGMENTS
TABLE 87. QUALIGEN INC.: PRODUCT PORTFOLIO
TABLE 88. THERMOFISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 89. THERMOFISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 90. THERMOFISHER SCIENTIFIC: PRODUCT PORTFOLIO:
LIST OF FIGURES
FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. MARKET PLAYER POSITIONING, 2018
FIGURE 03. GLOBAL THYROID FUNCTION TEST MARKET SEGMENTATION
FIGURE 04. IMPACT ANALYSIS
FIGURE 05. COMPARATIVE ANALYSIS OF TSH TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 06. COMPARATIVE ANALYSIS OF T3 TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 07. COMPARATIVE ANALYSIS OF T4 TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 08. COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF DIAGNOSTIC LABORATORIES THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 10. COMPARATIVE ANALYSIS OF HOSPITALS THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF OTHERS THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 12. U.S. THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 13. CANADA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 14. MEXICO THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 15. GERMANY THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 16. FRANCE THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 17. UK THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 18. ITALY THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 19. SPAIN THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 20. REST OF EUROPE THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 21. JAPAN THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 22. CHINA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 23. AUSTRALIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 24. INDIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 25. SOUTH KOREA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 27. BRAZIL THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 28. SAUDI ARABIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 29. SOUTH AFRICA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 30. REST OF LAMEA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 31. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 32. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 33. DANAHER CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 34. DANAHER CORPORATION.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 35. DANAHER CORPORATION INC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 36. DIASORIN: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. DIASORIN: REVENUE SHARE BY REGION, 2018(%)
FIGURE 38. ROCHE: NET SALES, 2017–2018 ($MILLION)
FIGURE 39. ROCHE: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 40. ROCHE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 41. MERCK KGAA: NET SALES, 2016–2018 ($MILLION)
FIGURE 42. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 43. MERCK KGAA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 44. THERMOFISHER SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 45. THERMOFISHER SCIENTIFIC: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 46. THERMOFISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2018 (%)
The adoption of thyroid function test is expected to increase due to rise in number target population across the world and increase in awareness about thyroid function test in developing countries. Furthermore, surge in geriatric population, rise in awareness program, and increase in awareness of early screening of the disease further supports the market growth.
North America is expected to remain dominant during the forecast period, due to the presence of higher number of target population coupled with surge in use of thyroid function test screening and large presence of trained medical professionals. In addition, availability of advanced healthcare facilities and strong presence of key players supplement the growth of the market. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to rise in number of individuals suffering from thyroid disorders along with rise in demand for thyroid function tests.
A. The total market value of thyroid function test market is $1,190.30 million in 2018.
A. The forcast period for thyroid function test market is 2019 to 2026
A. The market value of thyroid function test market in 2019 is $1,255.20 million.
A. The base year is 2018 in thyroid function test market
A. Top companies such as, Abbott Laboratories, Merck KGaA, ThermoFisher Scientific, and Qualigen Inc held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. TSH tests segment is the most influencing segment owing to increase in prevalence of thyroid disorders and recommended usage of TSH test for preliminary screeninge
A. The major factor that fuels the growth of the global thyroid function test market includes increase in prevalence of thyroid disorders. This leads to surge in demand for thyroid funtion tests which contribute to the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 6.6%. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals & diagnostic centers equipped with advanced medical facilities.
A. Thyroid function test involves a series of blood tests used to measure adequacy of the levels of thyroid hormones. It involves the different types of tests such as T3, T4, TSH, and T3RU
A. Thyroid function test are employed to define whether the thyroid hormone production is normal, overactive, or underactive.
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report